Over the past year, 23andMe set new corporate governance lows. CEO Anne Wojcicki now enters de facto “founder mode” after a ...

With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to ...

Me helped usher in the era of consumer DNA test kits nearly two decades ago, but has more recently faced a series of setbacks ...

SUNNYVALE, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced ...

Stock splits are typically viewed as bullish indicators that a company sees more growth is on the horizon. Although nothing ...

A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Americans curious about their ancestry likely paid for a DNA test through 23andMe. But with their future unclear, what will ...

Here's how to delete your data as company shake-up leaves customers wondering what will happen to their DNA info.

Anne Wojcicki, the CEO of the consumer genetic testing company 23andMe (ME), is cautiously optimistic about the firm’s future ...

Shares in 23andMe are "worth pennies", said NPR last Thursday. Its valuation has "plummeted 99% from its $6 billion peak ...

Here is a look at why companies split their stocks and why stock splits matter. Plus, upcoming splits to watch from 23andMe ...

Oct. 11, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), announced today that the 1-for-20 reverse stock split of the Company’s Class A and Class B common stock ...